With the addition of immunotherapy and other novel targeted agents to the treatment armamentarium for advanced bladder cancer, the care landscape for urothelial carcinoma is evolving. Keep the entire multidisciplinary care team up-to-date with information and resources from the ACCC education program on Optimizing Outcomes for Urothelial Carcinoma in the Community Setting. Two options for participation: a live, on-site learning workshop or as an audio-guided web course.
This education activity will provide guidance on the optimal management of mCSPC to oncologists, urologists, oncology advanced practitioners and other members of the multidisciplinary cancer care team. The educational program will address some of the challenges in optimal sequencing of care in mCSPC and will provide an opportunity to discuss with leading oncology experts and colleagues how new research clinical updates can be translated into new patient care strategies.
Learn More & Register
Could your cancer care team benefit from expert guidance and strategies for coping with common challenges in delivery of immunotherapy? ACCC is offering three upcoming workshop opportunities through the Best Practices for Implementing Cancer Immunotherapy in the Community education program.
Request to Host